Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WaveLight is a leading medical technology company specializing in the development and manufacture of advanced laser systems for refractive eye surgery. Based in Erlangen, Germany, the company gained international recognition for its Allegretto Wave excimer laser, which introduced wavefront-optimized technology to the LASIK industry. Following its acquisition by Alcon, WaveLight's innovations have been integrated into a comprehensive refractive suite that includes both excimer and femtosecond lasers. These systems are designed to treat a wide range of vision impairments, including myopia, hyperopia, and astigmatism, with high precision and safety. The company continues to drive innovation in the field of ophthalmology through its topography-guided treatment platforms like Contoura Vision. WaveLight remains a core component of Alcon's surgical portfolio, serving clinics and hospitals worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WaveLight.